To match as closely as possible the in-vitro- and in-vivo-infected cells, for all subsequent analyses, we restricted our analyses of infected cells to those with low levels of CD4, which are, likely, cells at a later stage in the HIV infection cycle. This evidence concerns the gene CD4 and HIV infectious disease.